Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis
Abstract
Background: Few studies have compared the efficacy and safety of omadacycline with other treatments for acute bacterial skin and skin structure infections (ABSSSI). Therefore, updated meta-analyses on this topic is necessary.
Methods: We conducted a network meta-analysis (NMA) of randomized controlled trials (RCTs) to compare omadacycline with other anti-MRSA antibiotics. A systematic search of seven databases was undertaken to identify eligible RCTs enrolling adults with ABSSSI. Two reviewers independently assessed the quality of the included studies and three reviewers independently extracted data from all manuscripts. All meta-analyses were performed using R software.
Results: Our NMA included 39 RCTs with a total of 20,862 patients with ABSSSI. Eighteen anti-MRSA antibiotics were analyzed in the NMA. In terms of early clinical response, omadacycline was comparable to oxazolidinones like linezolid, tedizolid, and contezolid. Across various populations, including the intention-to-treat (ITT), modified ITT, and clinically evaluable populations, omadacycline showed higher or comparable clinical success rates, although these results were of borderline statistical significance. The results showed that omadacycline ranked first in efficacy among 18 antibiotics, based on surface under the cumulative ranking curve values. Additionally, omadacycline had significantly fewer serious adverse events than telavancin and demonstrated a safety profile comparable to other antibiotics.…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 20,862 participants or records.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.